Overview
Acrocephalosyndactyly (ACS) is an obsolete umbrella term that was historically used to describe a group of rare congenital malformation syndromes characterized by the combination of acrocephaly (a pointed or tower-shaped skull due to premature fusion of cranial sutures, also known as craniosynostosis) and syndactyly (fusion or webbing of the fingers and/or toes). This term encompassed several distinct genetic conditions that are now classified separately, including Apert syndrome (ACS type I), Saethre-Chotzen syndrome (ACS type III), Pfeiffer syndrome (ACS type V), and other related craniosynostosis syndromes. Because these conditions have been individually characterized with distinct genetic etiologies, the grouped designation of acrocephalosyndactyly is no longer in active clinical use and is considered obsolete in current nosology. The conditions formerly grouped under this term primarily affect the skeletal system, particularly the craniofacial bones and the extremities. Premature fusion of one or more cranial sutures leads to abnormal skull shape and can result in increased intracranial pressure, which may affect brain development and vision if untreated. Syndactyly ranges from mild cutaneous webbing to complex bony fusion of digits. Additional features may include midface hypoplasia, hypertelorism, and intellectual disability of variable severity depending on the specific syndrome. Treatment for the individual conditions within this former grouping typically involves multidisciplinary surgical management, including staged craniofacial surgery to release fused sutures and reconstruct the skull, hand surgery to separate fused digits, and supportive therapies such as speech therapy and developmental support. Genetic counseling is recommended for affected families, as most of the individual syndromes follow autosomal dominant inheritance patterns, often involving mutations in fibroblast growth factor receptor (FGFR) genes or TWIST1.
Also known as:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Acrocephalosyndactyly.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Acrocephalosyndactyly at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Acrocephalosyndactyly.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Acrocephalosyndactyly.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Acrocephalosyndactyly.
Start the conversation →Latest news about OBSOLETE: Acrocephalosyndactyly
No recent news articles for OBSOLETE: Acrocephalosyndactyly.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Acrocephalosyndactyly
What is OBSOLETE: Acrocephalosyndactyly?
Acrocephalosyndactyly (ACS) is an obsolete umbrella term that was historically used to describe a group of rare congenital malformation syndromes characterized by the combination of acrocephaly (a pointed or tower-shaped skull due to premature fusion of cranial sutures, also known as craniosynostosis) and syndactyly (fusion or webbing of the fingers and/or toes). This term encompassed several distinct genetic conditions that are now classified separately, including Apert syndrome (ACS type I), Saethre-Chotzen syndrome (ACS type III), Pfeiffer syndrome (ACS type V), and other related craniosyno
How is OBSOLETE: Acrocephalosyndactyly inherited?
OBSOLETE: Acrocephalosyndactyly follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Acrocephalosyndactyly typically begin?
Typical onset of OBSOLETE: Acrocephalosyndactyly is neonatal. Age of onset can vary across affected individuals.